Page last updated: 2024-08-22

tiletamine hydrochloride and Adenocarcinoma of Lung

tiletamine hydrochloride has been researched along with Adenocarcinoma of Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asthana, S; Bandyopadhyay, S; Bivona, TG; Blakely, CM; Bobb, KL; Chan, E; Fouts, TR; Gubens, MA; Hrustanovic, G; Jablons, DM; Johnson, JR; Krogan, NJ; Lin, L; Meshulam, J; Neel, DS; Newton, W; Olivas, V; Pazarentzos, E; Tan, I; Yan, JJ	1

Other Studies

1 other study(ies) available for tiletamine hydrochloride and Adenocarcinoma of Lung

Article	Year
NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer. Cell reports, 2015, Apr-07, Volume: 11, Issue:1 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cyclohexanones; Drug Resistance, Neoplasm; Epoxy Compounds; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Kinase; Lung Neoplasms; Molecular Targeted Therapy; NF-kappa B; Nuclear Pore Complex Proteins; Proto-Oncogene Proteins c-akt; RNA-Binding Proteins; Signal Transduction; TNF Receptor-Associated Factor 2	2015

Article

Year

NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer.

Cell reports, 2015, Apr-07, Volume: 11, Issue:1

Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cyclohexanones; Drug Resistance, Neoplasm; Epoxy Compounds; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Kinase; Lung Neoplasms; Molecular Targeted Therapy; NF-kappa B; Nuclear Pore Complex Proteins; Proto-Oncogene Proteins c-akt; RNA-Binding Proteins; Signal Transduction; TNF Receptor-Associated Factor 2

2015